Modification [ftcn]
Lipid [lipd]
Pattern [spco]
Post-Menopause [orgf]
Women [popg]
Hormone replacement therapy [topp]
Evaluated [ftcn]
Lipid [lipd]
Pattern [spco]
Menopause [phsf]
influential [idcn]
Hormone replacement therapy [topp]
Parameters [fndg]
Methods [inpr]
considered [idcn]
Patients [podg]
divided [ftcn]
Group [idcn]
Group I [inpr]
Women [popg]
Physiological [ftcn]
Surgical menopause [dsyn]
Group [idcn]
Ii [aapp]
Women [popg]
considered [idcn]
Group [idcn]
III [inpr]
Formed [ftcn]
Patients [podg]
Menopausal [phsf]
Women [popg]
Group I [inpr]
months [tmco]
Hormone replacement therapy [topp]
Evaluated [ftcn]
Total Cholesterol [lbpr]
Cholesterol, HDL [bacs, lipd]
Cholesterol, LDL [bacs, strd]
Triglycerides [bacs, lipd]
Lipoprotein (a) [aapp, bacs]
LPA [lbpr]
Fibrinogen [aapp, bacs, phsu]
Antithrombin III [aapp, phsu]
Factor VII [aapp, bacs, phsu]
Tissue factor pathway inhibitor [aapp, phsu]
worse [qlco]
Lipid [lipd]
Profile [lbpr]
postmenopausal [tmco]
Group [idcn]
Compared [acty]
Total Cholesterol [lbpr]
9-MG [nnon]
P NOS [aapp, imft]
Triglycerides [bacs, lipd]
mg% [qnco]
P NOS [aapp, imft]
Cholesterol, LDL [bacs, strd]
mg% [qnco]
P NOS [aapp, imft]
Cholesterol, HDL [bacs, lipd]
mg% [qnco]
P NOS [aapp, imft]
Pattern [spco]
Fibrinogen [aapp, bacs, phsu]
Post-Menopause [orgf]
Group [idcn]
Fibrinogen [aapp, bacs, phsu]
mg% [qnco]
P NOS [aapp, imft]
Antithrombin III [aapp, phsu]
P NOS [aapp, imft]
Factor VII [aapp, bacs, phsu]
mg% [qnco]
P NOS [aapp, imft]
tissue-factor-pathway inhibitor 2 [aapp, bacs]
activity [dora]
P NOS [aapp, imft]
Tissue factor pathway inhibitor [aapp, phsu]
Antigen [imft]
U/ml [qnco]
P NOS [aapp, imft]
Same [qlco]
Parameters [fndg]
months [tmco]
Hormone replacement therapy [topp]
Patients [podg]
Group [idcn]
III [inpr]
Observed [ftcn]
Improvement [cnce]
Total Cholesterol [lbpr]
Triglyceride level [lbtr]
Total Cholesterol [lbpr]
mg% [qnco]
P NOS [aapp, imft]
Triglycerides [bacs, lipd]
mg% [qnco]
P NOS [aapp, imft]
Cholesterol, HDL [bacs, lipd]
mg% [qnco]
P NOS [aapp, imft]
Cholesterol, LDL [bacs, strd]
mg% [qnco]
P NOS [aapp, imft]
Following [tmco]
Observed [ftcn]
Parameters [fndg]
Fibrinogen [aapp, bacs, phsu]
mg% [qnco]
P NOS [aapp, imft]
Antithrombin III [aapp, phsu]
mg% [qnco]
P NOS [aapp, imft]
Factor VII [aapp, bacs, phsu]
mg% [qnco]
0.014" [qnco]
Tissue factor pathway inhibitor [aapp, phsu]
activity [dora]
P NOS [aapp, imft]
Tissue factor pathway inhibitor [aapp, phsu]
Antigen [imft]
U/ml [qnco]
P NOS [aapp, imft]
Conclusions [idcn]
Alteration [idcn]
Lipid [lipd]
Pattern [spco]
Post-Menopause [orgf]
Women [popg]
Hormone replacement therapy [topp]
INT [orch]
